These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21419653

  • 1. A comparison of the effect of aprotinin and ε-aminocaproic acid on renal function in children undergoing cardiac surgery.
    Leyvi G, Nelson O, Yedlin A, Pasamba M, Belamarich PF, Nair S, Cohen HW.
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):402-6. PubMed ID: 21419653
    [Abstract] [Full Text] [Related]

  • 2. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 3. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience.
    Fan Y, Lin R, Yang L, Ye L, Yu J, Shu Q.
    Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963
    [Abstract] [Full Text] [Related]

  • 4. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA, Evans FM, Rosenberg ES, Fazlollah TM, Baker MJ, Wilson EC, Kaiser AM, Tosone SR, Miller BE.
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [Abstract] [Full Text] [Related]

  • 5. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT.
    Am J Nephrol; 2008 Feb; 28(4):576-82. PubMed ID: 18264006
    [Abstract] [Full Text] [Related]

  • 6. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A, Jooste EH, Kuch BA, Lichtenstein SE, Morell V, Munoz R, Ellis D, Davis PJ.
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [Abstract] [Full Text] [Related]

  • 7. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC, Reames MK, Skipper E, Stiegel RM, Nussbaum M, Geller R, Robicsek F, Lobdell KW.
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aprotinin and renal dysfunction after pediatric cardiac surgery.
    Székely A, Sápi E, Breuer T, Kertai MD, Bodor G, Vargha P, Szatmári A.
    Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND.
    Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [Abstract] [Full Text] [Related]

  • 16. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.
    Int J Clin Exp Pathol; 2015 Oct; 8(7):7978-87. PubMed ID: 26339364
    [Abstract] [Full Text] [Related]

  • 17. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 18. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [Abstract] [Full Text] [Related]

  • 19. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF.
    N Engl J Med; 2008 Feb 21; 358(8):784-93. PubMed ID: 18287601
    [Abstract] [Full Text] [Related]

  • 20. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.
    Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.
    Br J Anaesth; 2013 Apr 21; 110(4):615-21. PubMed ID: 23213034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.